Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

Berthold Hocher(Charité - Universitätsmedizin Berlin), Christa Thöne‐Reineke(Institute of Molecular Biology), Peter Rohmeiss(Heidelberg University), Fred Schmager, Torsten Slowinski(Freie Universität Berlin), Volker Burst(Heidelberg University), F Siegmund, Thomas Quertermous(Vanderbilt University), C. Bauer(Freie Universität Berlin), H.-H. Neumayer(Humboldt-Universität zu Berlin), Wolf‐Dieter Schleuning, Franz Theuring
Journal of Clinical Investigation
March 15, 1997
Cited by 410Open Access
Full Text

Abstract

The human endothelin-1 (ET-1) gene under the control of its natural promoter was transferred into the germline of mice. The transgene was expressed predominantly in the brain, lung, and kidney. Transgene expression was associated with a pathological phenotype manifested by signs such as age-dependent development of renal cysts, interstitial fibrosis of the kidneys, and glomerulosclerosis leading to a progressive decrease in glomerular filtration rate. This pathology developed in spite of only slightly elevated plasma and tissue ET-1 concentrations. Blood pressure was not affected even after the development of an impaired glomerular filtration rate. Therefore, these transgenic lines provide a new blood pressure-independent animal model of ET-1-induced renal pathology leading to renal fibrosis and fatal kidney disease.


Related Papers

No related papers found

Powered by citation graph analysis